Growth inhibitory effect of stevioside on ovarian cancer through Akt/ERK pathway

Biomedical Research (India)

Volumn 28, Issue 4, 2017, Pages 1820-1827

  Li, Xiao Yan ^a   Lu, Wen Ming ^b   Shen, Wen Feng ^a   Wu, Yan ^a   Liu, Ya Ping ^a   Tuo, Ya ^a   Liu, Yan Long ^a  

^a Affiliated Hospital of Inner Mongolia Medical University   (China)

^b The First People s Hospital of Huzhou City   (China)

Author keywords

Apoptosis; Growth inhibition; Ovarian cancer; Signaling pathway; Stevioside

Indexed keywords

CASPASE 3; CASPASE 9; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STEVIOSIDE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; ENZYME INACTIVATION; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MITOCHONDRIAL MEMBRANE POTENTIAL; OVARIAN CANCER CELL LINE; OVARY CANCER; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

EID: 85014382972     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Memarzadeh S, Berek JS. Advances in the management of epithelial ovarian cancer. J Reprod Med 2001; 46: 621-629.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Yap TA, Carden CP, Kaye SB. Beyond chemotherapy: targeted therapies in ovarian cancer. Nat Rev Cancer 2009; 9: 167-181.
4. Bast RC Jr, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 2009; 9: 415-428.
5. Pfisterer J, Ledermann JA. Management of platinumsensitive recurrent ovarian cancer. Semin Oncol 2006; 33: S12-16.
6. Blackledge G, Lawton F, Redman C, Kelly K. Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials. Br J Cancer 1989; 59: 650-653.
7. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-780.
8. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006; 71: 1397-1421.
9. Vergara D, Simeone P, Toraldo D, Del Boccio P, Vergaro V. Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells. Mol Biosyst 2012; 8: 1078-1087.
10. Ren MX, Deng XH, Ai F, Yuan GY, Song HY. Effect of quercetin on the proliferation of the human ovarian cancer cell line SKOV-3 in vitro. Exp Ther Med 2015; 10: 579-583.
11. Chen J, Chen AY, Huang H, Ye X, Rollyson WD. The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway. Int J Oncol 2015; 46: 2629-2638.
12. Huh SW, Bae SM, Kim YW, Lee JM, Namkoong SE. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol 2004; 94: 760-768.
13. Luo H, Rankin GO, Li Z, Depriest L, Chen YC. Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway. Food Chem 2011; 128: 513-519.
14. Tang AQ, Cao XC, Tian L, He L, Liu F. Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3derived sphere-forming cells. Mol Med Rep 2015; 11:2221-2226.
15. Hanson JR, De Oliveira BH. Stevioside and related sweet diterpenoid glycosides. Nat Prod Rep 1993; 10: 301-309.
16. Gregersen S, Jeppesen PB, Holst JJ, Hermansen K. Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism 2004; 53: 73-76.
17. Chatsudthipong V, Muanprasat C. Stevioside and related compounds: therapeutic benefits beyond sweetness. Pharmacol Ther 2009; 121: 41-54.
18. Gasmalla MAA, Yang R, Musa A, Hua X, Zhang W. Physico-chemical Assessment and Rebauidioside A. Productively of Natural Sweeteners (Stevia Rebaudiana Bertoni). J Food Nutr Res 2014; 2: 209-214.
19. Paul S, Sengupta S, Bandyopadhyay TK, Bhattacharyya A. Stevioside induced ROS-mediated apoptosis through mitochondrial pathway in human breast cancer cell line MCF-7. Nutr Cancer 2012; 64:1087-1094.
20. Park HR, Furihata K, Hayakawa Y, Shin-ya K. Versipelostatin, a novel GRP78/Bip molecular chaperone down-regulator of microbial origin. Tetrahedron Letters 2002; 43: 6941-6945.
21. Chang J, Hsu Y, Kuo P, Kuo Y, Chiang L, Lin C. Increase of Bax/ Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sciences 2005; 76: 1883-1893.
22. Vijayababu MR, Kanagaraj P, Arunkumar A, Ilangovan R, Aruldhas MM, Arunakaran J. Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J Cancer Res Clin Oncol 2005; 131: 765-771.
23. Curtin JF, Donovan M, Cotter TG. Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 2002; 265: 49-72.
24. Rizzo B, Zambonin L, Angeloni C, Leoncini E, Vieceli Dalla Sega F, Prata C, Fiorentini D, Hrelia S. Steviol Glycosides Modulate Glucose Transport in Different Cell Types. Oxidative Medicine and Cellular Longevity 2013; 2013: 11.
25. Martinez-Outschoorn UE, Lin Z, Trimmer C, Flomenberg N, Wang C, Pavlides S, Pestell RG, Howell A, Sotgia F, Lisanti MP. Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle 2011; 10: 2504-2520.
26. Lin JP, Yang JS, Chang NW, Chiu TH, Su CC. GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res 2007; 27: 3379-3386.
27. Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 2003; 8: 115-128.
28. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 2001; 26: 657-664.
29. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002; 14: 381-395.
30. Yasukawa K, Kitanaka S, Seo S. Inhibitory effect of stevioside on tumor promotion by 12-Otetradecanoylphorbol- 13-acetate in two-stage carcinogenesis in mouse skin. Biol Pharm Bull 2002; 25: 1488-1490.
31. Mizushina Y, Akihisa T, Ukiya M, Hamasaki Y, Murakami- Nakai C, Kuriyama I, Takeuchi T, Sugawara F, Yoshida H. Structural analysis of isosteviol and related compounds as DNA polymerase and DNA topoisomerase inhibitors. Life Sci 2005; 77: 2127-2140.
32. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995; 182:367-377.
33. Franco R, Cidlowski JA. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ 2009; 16: 1303-1314.
34. O'Rourke TW, Doudican NA, Mackereth MD, Doetsch PW, Shadel GS. Mitochondrial dysfunction due to oxidative mitochondrial DNA damage is reduced through cooperative actions of diverse proteins. Mol Cell Biol 2002; 22:4086-4093.
35. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
36. Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 2006; 141: 312-322.
37. Gollapudi S, McCormick MJ, Gupta S. Changes in mitochondrial membrane potential and mitochondrial mass occur independent of the activation of caspase-8 and caspase-3 during CD95-mediated apoptosis in peripheral blood T cells. Int J Oncol 2003; 22:597-600.
38. Cain K, Bratton SB, Cohen GM. The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie 2002; 84:203-214.
39. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266: 1821-1828.
40. Sun J, Hai Liu R. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett 2006; 241: 124-134.
41. Chan TO, Rittenhouse SE, Tsichlis PN. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999; 68: 965-1014.
42. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: 1318-1321.